Google Alert - pharmaceutical news

News 3 new results for pharmaceutical news

Buy MAP Pharmaceutical For 70% Upside Seeking Alpha MAP Pharmaceuticals (MAPP) saw an appreciation of 20% on Friday. We believe this is just the start of an epic run for MAPP shareholders. The company's application for LEVADEX was rejected by FDA back in March due to CMC issues and no objections ... See all stories on this topic »

Barely surviving to thriving - a remarkable 27-year journey with HIV Canada NewsWire (press release) After three months the HIV virus could no longer be detected in his system. Tiko now lives an active healthy life, and continues his work as a visual artist in Vancouver. (CNW Group/CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)) ... See all stories on this topic » Canada NewsWire (press release)

China Nuokang Bio-Pharmaceutical Inc posts lower net income of CNY2.5m for ... MENAFN.COM Nov 26, 2012 (Menafn - M2 EQUITYBITES via COMTEX) --Biopharmaceutical company China Nuokang Bio-Pharmaceutical Inc (nasdaqgm:NKBP) stated on Sunday its net income of CNY2.5m (CNY0.13 per diluted ADS) for the third quarter of 2012. See all stories on this topic »

---

Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.